Dihydropyridine

Products Dihydropyridines are commercially available in many countries in the form of film-coated tablets, sustained-release tablets, capsules, and injectables. Nifedipine from Bayer (Adalat) was the first active ingredient from this group to enter the market in the mid-1970s. Today, amlodipine (Norvasc, generics) is most commonly prescribed. Structure and properties The name 1,4-dihydropyridines is derived from … Dihydropyridine

Damoctocog Alfa Pegol

Products Damoctocog alfa pegol was approved as a preparation for solution for injection in the United States and the EU in 2018 and in many countries in 2019 (Jivi). Structure and properties Damoctocog alfa pegol is a pegylated, B-domain-deleted, conjugated, recombinant blood coagulation factor VIII (rFVIII). The molecular mass is approximately 234 kDa. The drug … Damoctocog Alfa Pegol

Solifenacin

Products Solifenacin is commercially available in the form of film-coated tablets (Vesicare, generics). It has been approved in many countries since 2006. Structure and properties Solifenacin (C23H26N2O2, Mr = 362.5 g/mol) is a tertiary amine and a phenylquinoline derivative that has structural similarities to atropine. It is present in drugs as (1)-(3)-solifenacin succinate, a white … Solifenacin

Esomeprazole

Products Esomeprazole is commercially available as tablets, film-coated tablets, granules for oral suspension, and injectables (Nexium, generics). It has been approved in many countries since 2000. Generics entered the market in 2012. Fixed combinations: Naproxen and esomeprazole (Vimovo, 2011). Acetylsalicylic acid and esomeprazole (Axanum, 2012), not commercially available. Structure and properties Esomeprazole (C17H19N3O3S, Mr = … Esomeprazole

Aliskiren

Products Aliskiren is commercially available in the form of film-coated tablets (Rasilez, Rasilez HCT + hydrochlorothiazide). It was approved in many countries, in the EU and in the United States in 2007 (Other brand name: Tekturna). Note: Other combination preparations, e.g., with amlodpine (Rasilamlo), are no longer available. Structure and properties Aliskiren (C30H53N3O6, Mr = … Aliskiren

Plasma Concentration

Definition Plasma concentration is the concentration of a pharmaceutical agent in blood plasma at a given time after administration. Plasma is the liquid portion of blood excluding its cellular components. Concentration is typically expressed in µg/ml. Plasma concentration-time curves If plasma levels are measured several times after administration, a plasma concentration-time curve can be constructed … Plasma Concentration